Analysis of agreement between dobutamine stress echocardiography and exercise nuclear angiography in severe aortic regurgitation

sclerosis patients. Alternative Therap Health Med 1996;2:75–79. 8. Wallace RK, Benson H, Wilson AF. A wakeful hypometabolic state. Am J Phys 1971;3:795–799. 9. Benson H, Malhoutra M, Goldman R, Jacobs G, Hopkins P. Three case reports of the metabolic and electroencephalographic changes during advance Buddhist meditation techniques. Behav Med 1990;16:90–95. 10. Ornish D, Scherwitz LW, Doody RS, et al. Effect of stress management training and dietary changes in treating ischemic heart disease. JAMA 1983;249: 54–59. 11. Rector TS, Kubo SH, Cohn JN. Patients’ self-assessment of their congestive heart failure. Part 2: Content reliability and validity of a new measure, the Minnesota Living with Heart Failure questionnaire. Heart Failure 1987;198– 209. 12. Guyatt GH. Thompson PJ. Berman LB, Sullivan M, Townsend M, Jones N, Pugseey S. How should we measure function in patients with chronic heart and lung disease? J Chronic Dis 1985;38:517–524. 13. McGavin CR, Artvinli M, Naol H. Dyspnea, disability and distance walked: comparison of extimates of exercise performance in respiratory disease. BMJ 1978;2:241–243. 14. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea: contents, interobserver agreement and physiologic correlates of two new clinical indexes. Chest 1984;85:751–58. 15. Borg GAV. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377–381. 16. Epstein G, Barrett EAM, Halper JP, Seriff NS, et al. Alleviating asthma with mental imagery: a phenomenological approach. Alternative Complement Therap1997. 17. Cohn J, Goldstein S, Greenberg B, Lorell B, Bourge R, Jaski B, Gottlieb S, McGrew F, DeMets D, White B. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N Eng J Med 1998;339: 1810–1816. 18. Kubo S, Gollub S, Bourge R, Rahko P, Cobb F, Jessup M, Brozena S, Brodsky M, Kirlin D, Shanes J. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. Circulation 1992;85:942–999. 19. Konstam V, Salem D, Pouleur H, Kostis J, Gorkin L, Shumaker S, Mottard I, Woods P, Konstam M, Yusuf S. Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. Am J Cardiol 196;78:890–895. 20. Epstein G. Healing Visualizations: Creating Health Through Imagery. New York: Bantam, 1989.